Overweight & Obesity

US FDA approves Wegovy to cut risk of heart problems

The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.

Diseases, Conditions, Syndromes

NY bill would force insurers to cover copays for Paxlovid

With the life-saving, COVID-fighting drug Paxlovid no longer covered by the federal government, a push is underway in Albany to ensure New Yorkers seeking the medication do not get gouged by pricey co-payments.

Medications

Latest obesity drug not cost-effective for adolescents

Among today's obesity drugs, Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers has found that the trendy obesity drug is not cost-effective at its current price.

page 1 from 11